NIH-funded research NIH-funded research

Toward a cure for Hepatitis B using DNA-targeting PNAs

Official title: Toward a Curative Treatment for HBV with cccDNA-Targeting Peptide Nucleic Acids

Funded at Wake Forest University Health Sciences · NIH-11515047 · Data updated 2026-11-12

Aims to develop a new, liver-targeted therapy that could remove persistent HBV DNA from liver cells to potentially cure infection.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWake Forest University Health Sciences
NIH-funded
Lab location1 site (Winston-Salem, United States)
Project startFebruary 15, 2024
Project endAugust 31, 2029
Funding year2026
Award (this year)$476,493
NIH project number4R33AI180006-03
Project IDNIH-11515047 on NIH RePORTER

Who could benefit from this research

Could help

People living with chronic HBV infection who might benefit from future curative therapies.

Less likely to help

Individuals without HBV infection or those who are not candidates for nucleic acid–based liver-targeted therapies.

What this research studies

This project seeks to create peptide nucleic acids (PNAs) that can directly bind and degrade the HBV cccDNA stored in liver cells. The approach explores how PNAs can be delivered to the liver and targeted to the virus’ DNA with high specificity and low toxicity. If successful, this could complement existing vaccines and antivirals by addressing the stubborn cccDNA reservoir that keeps HBV infections alive. The research will establish sensitive assays to detect cccDNA changes and evaluate safety and delivery in relevant models.

Why it matters

Potential benefit: If successful, this work could lead to a curative therapy for HBV by eradicating the virus’ hidden DNA in liver cells.

How similar studies have gone: Past work with liver-targeted nucleic acid therapies shows promise, but direct cccDNA degradation remains a novel area.

Where this research is happening

  • Wake Forest University Health Sciences
    Winston-Salem, United States
    Active

Researchers

  • Principal investigator: Gagnon, Keith Thomas — Wake Forest University Health Sciences
  • Study coordinator: Gagnon, Keith Thomas

Related research

Other NIH-funded projects on the same topics.

  • Evaluating a combined approach to manage chronic pain

    This study is looking at whether taking duloxetine along with online therapy can help people with chronic pain feel better, and it includes some support to help you stick with the therapy; you'll be randomly placed in one of three groups to see which approach works best over six months.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-9870024

  • Drd3 gene variants and cocaine seeking in rats

    A study in rats will map different Drd3 gene variants to how cocaine-seeking and taking behavior is influenced, aiming to uncover targets for treating cocaine use disorder.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11619073

  • Intensive dental care during cancer follow-up to protect teeth after head and neck radiation

    A program delivered in oncology clinics to provide fluoride varnish and dental follow-up aims to reduce tooth decay and improve oral health and quality of life for head and neck cancer patients after radiation therapy.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11575645

  • Wake Forest NCORP Cancer Center Research Base

    A patient-focused opportunity to advance real-world cancer care through community-based studies that address how cancer and its treatments affect daily life and well-being.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11543565

  • Hybrid approach to peer-supported mood and incentive program to reduce HIV risk among women who inject drugs

    A pilot program tests a combined peer-supported mood-boosting approach with contingency management to help stimulant-using women who inject drugs reduce HIV risk.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11537936

  • Coordinating Center for the MoTrPAC project

    A large nationwide effort seeks to map how physical activity changes the body at the molecular level, with a coordinating center that handles data, biospecimens, and collaboration across sites.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11537917

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.